Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Before investing your money, it's essential to understand key factors. Get informed to make the best investment decisions.
21,805 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Casey’s General Stores prepares to report Q4 results after the bell, with analysts weighing margins in prepared foods...
UK banks are tightening crypto transfer rules, triggering a pushback from crypto advocates. Industry groups estimate ...
Alphabet’s billion flex is more than just cash. It’s a strategic playbook that powers buybacks, AI investments, and l...
Amazon’s warning triggered a White House move to restrict overseas access to Anthropic’s Mythos AI, signaling heighte...
Colgate-Palmolive topped earnings expectations and posted stronger cash flow, positioning it as a top defensive pick ...
In 2012, Meta paid $1 billion for Instagram, a move many called reckless. Today, that decision is seen as a cornersto...
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
Prediction markets are soaring as the 2026 World Cup kicks into high gear, with multi-billion volumes on Kalshi, Poly...
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
A timely, original look at the Vanguard Dividend Appreciation ETF through a dividend safety check: dividend framework...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...